HK1178888A1 - Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring - Google Patents

Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring

Info

Publication number
HK1178888A1
HK1178888A1 HK13105594.4A HK13105594A HK1178888A1 HK 1178888 A1 HK1178888 A1 HK 1178888A1 HK 13105594 A HK13105594 A HK 13105594A HK 1178888 A1 HK1178888 A1 HK 1178888A1
Authority
HK
Hong Kong
Prior art keywords
carboxylic acid
acid derivatives
heterocyclic carboxylic
oxazolopyrimidine ring
substituted oxazolopyrimidine
Prior art date
Application number
HK13105594.4A
Other languages
English (en)
Inventor
Dieter Kadereit
Matthias Schaefer
Stephanie Hachtel
Axel Dietrich
Thomas Huebschle
Andreas Gille
Katrin Hiss
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of HK1178888A1 publication Critical patent/HK1178888A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
HK13105594.4A 2010-01-13 2013-05-10 Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring HK1178888A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10305037 2010-01-13
PCT/EP2011/050299 WO2011086078A1 (de) 2010-01-13 2011-01-12 Heterocyclische carbonsäurederivate mit einem 2,5,7-substituiertem oxazolopyrimidinring

Publications (1)

Publication Number Publication Date
HK1178888A1 true HK1178888A1 (en) 2013-09-19

Family

ID=41820658

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13105594.4A HK1178888A1 (en) 2010-01-13 2013-05-10 Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring

Country Status (21)

Country Link
US (1) US8846691B2 (xx)
EP (1) EP2523959B1 (xx)
JP (1) JP5844278B2 (xx)
KR (1) KR101759121B1 (xx)
CN (1) CN102906098B (xx)
AR (1) AR079982A1 (xx)
AU (1) AU2011206614B8 (xx)
BR (1) BR112012017240A2 (xx)
CA (1) CA2792134C (xx)
DK (1) DK2523959T3 (xx)
ES (1) ES2449705T3 (xx)
HK (1) HK1178888A1 (xx)
IL (1) IL220708A (xx)
MX (1) MX2012007833A (xx)
MY (1) MY156551A (xx)
PT (1) PT2523959E (xx)
RU (1) RU2554869C2 (xx)
SG (1) SG182473A1 (xx)
TW (1) TWI517851B (xx)
UY (1) UY33178A (xx)
WO (1) WO2011086078A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI485153B (zh) 2010-01-13 2015-05-21 Sanofi Aventis ２，５，７－經取代唑并嘧啶衍生物
JP5841067B2 (ja) * 2010-01-14 2016-01-06 サノフイ ２，５−置換されたオキサゾロピリミジン環を有するカルボン酸誘導体
MX2012007837A (es) * 2010-01-14 2012-07-30 Sanofi Sa Derivados de oxazolopirimidina 2, 5 - sustituidos.
AR079884A1 (es) * 2010-01-14 2012-02-29 Sanofi Aventis Derivados de acido carboxilico heterociclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida
US9321787B2 (en) 2011-07-07 2016-04-26 Sanofi Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679682A (en) * 1970-04-23 1972-07-25 Fmc Corp CERTAIN 5H-ISOXAZOLO{8 5,4-d{9 PYRIMIDIN-4-ONES
JP4944613B2 (ja) * 2003-05-19 2012-06-06 アイアールエム・リミテッド・ライアビリティ・カンパニー 免疫抑制化合物および組成物
DK1638551T3 (da) * 2003-05-19 2012-04-02 Irm Llc Immunosuppressive forbindelser og sammensætninger
WO2007061458A2 (en) * 2005-11-23 2007-05-31 Epix Delaware, Inc. S1p receptor modulating compounds and use thereof
CA2679980A1 (en) * 2007-03-21 2007-09-27 Epix Pharmaceuticals, Inc. S1p receptor modulating compounds and use thereof
TW201000099A (en) * 2008-06-20 2010-01-01 Amgen Inc S1P1 receptor agonists and use thereof

Also Published As

Publication number Publication date
AU2011206614B8 (en) 2015-03-05
CN102906098A (zh) 2013-01-30
IL220708A (en) 2015-02-26
RU2554869C2 (ru) 2015-06-27
US20130158051A1 (en) 2013-06-20
KR101759121B1 (ko) 2017-07-18
JP2013517240A (ja) 2013-05-16
MX2012007833A (es) 2012-07-20
CA2792134C (en) 2017-12-05
DK2523959T3 (en) 2014-03-10
TW201134472A (en) 2011-10-16
CN102906098B (zh) 2015-07-15
UY33178A (es) 2011-08-31
SG182473A1 (en) 2012-08-30
BR112012017240A2 (pt) 2016-03-22
AU2011206614A1 (en) 2012-08-02
JP5844278B2 (ja) 2016-01-13
RU2012134463A (ru) 2014-02-20
KR20120101593A (ko) 2012-09-13
TWI517851B (zh) 2016-01-21
PT2523959E (pt) 2014-03-10
CA2792134A1 (en) 2011-07-21
AU2011206614B2 (en) 2015-02-26
US8846691B2 (en) 2014-09-30
ES2449705T3 (es) 2014-03-20
WO2011086078A1 (de) 2011-07-21
AR079982A1 (es) 2012-03-07
EP2523959B1 (de) 2013-11-27
MY156551A (en) 2016-02-26
EP2523959A1 (de) 2012-11-21

Similar Documents

Publication Publication Date Title
ZA201206440B (en) [5,6]heterocyclic compound
EP2594566A4 (en) AROMATIC HETEROCYCLIC NITROGEN CYCLE DERIVATIVE
HK1187606A1 (zh) 取代的 -稠合含氮雜環化合物及其用途
IL214568A0 (en) Hetero ring derivative
IL225770A0 (en) Heterocyclic compounds
PL2531492T3 (pl) Pochodne 1,2,4-triazyno-4-aminy
PT2540728T (pt) Composto heterocíclico
ZA201300950B (en) Heterocyclic compound
EP2399914A4 (en) FUSED HETEROCYCLIC RING CONNECTION
ZA201206630B (en) Hetaryl-[1,8]naphthyridine derivatives
AP3589A (en) A novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes
HK1180314A1 (en) Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring 257-
HK1178886A1 (en) Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
HK1178885A1 (en) Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
IL220707A0 (en) 2,5,7-substituted oxazolopyrimidine derivatives
HK1178888A1 (en) Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring
EP2583965A4 (en) HETEROCYCLIC RING CONNECTION
EP2632255A4 (en) HETEROCYCLIC DIAZENIUM DIOLATE DERIVATIVES
SI2566849T1 (sl) Derivati 8-hidroksi-kinolina
ZA201204349B (en) New secondary 8-hydroxyquinoline 7-carboxamide derivatives
GB201021416D0 (en) Novel heterocyclic compounds
GB201009514D0 (en) Novel heterocyclic compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190107